SCHEMBL1345334

SCHEMBL1345334

CC(=O)c1nccn1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
FDPS P14324 1/20 0.45
ALDH1A1 P00352 6/20 0.45
POLB P06746 1/20 0.45
FGFR1 P11362 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
RAB9A P51151 2/20 0.44
NR4A1 P22736 1/20 0.43
NR4A2 P43354 1/20 0.43
NOTUM Q6P988 1/20 0.42
CYP1A2 P05177 4/20 0.42
CYP3A4 P08684 4/20 0.42
CYP2D6 P10635 4/20 0.42
CYP2C9 P11712 4/20 0.42
CYP2C19 P33261 4/20 0.42
TP53 P04637 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
KDM4E B2RXH2 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27633478 0.85 ALDH1A1 (0.50) SMN1; SMN2FDPSALDH1A1POLBMEN1
SCHEMBL4539019 0.85 SMN1; SMN2 (0.48) SMN1; SMN2FDPSALDH1A1POLBFGFR1
SCHEMBL22290222 0.83 TP53 (0.43) SMN1; SMN2ALDH1A1RAB9ANR4A1NR4A2
SCHEMBL7443999 0.82 SMN1; SMN2 (0.46) SMN1; SMN2FDPSALDH1A1POLBFGFR1
SCHEMBL22290179 0.81 KMT2A (0.50) SMN1; SMN2FDPSALDH1A1POLBFGFR1
SCHEMBL27807039 0.78 ALDH1A1 (0.48) SMN1; SMN2FDPSALDH1A1POLBMEN1
SCHEMBL11177528 0.78 AKT1 (0.43) SMN1; SMN2FDPSALDH1A1POLBMEN1
SCHEMBL20028039 0.78 GABRA2 (0.52) SMN1; SMN2ALDH1A1POLBRAB9ATP53
SCHEMBL27997623 0.76 HPGD (0.46) SMN1; SMN2FDPSALDH1A1MEN1KMT2A
SCHEMBL22290363 0.74 NR4A1 (0.49) SMN1; SMN2ALDH1A1POLBRAB9ANR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194578-A1 PLATINUM COMPLEX AND OLED USING THE SAME NATIONAL TSING HUA UNIVERSITY (TW) 2017-07-06 US disclosed
US-20170194578-A1 PLATINUM COMPLEX AND OLED USING THE SAME NATIONAL TSING HUA UNIVERSITY (TW) 2017-07-06 US disclosed
US-8062767-B2 Organic light emitting diode containing a Ir complex having a novel ligand as a phosphorescent emitter Cheng, Chien-Hong (TW) 2011-11-22 US disclosed
US-8062767-B2 Organic light emitting diode containing a Ir complex having a novel ligand as a phosphorescent emitter Cheng, Chien-Hong (TW) 2011-11-22 US disclosed
US-8062767-B2 Organic light emitting diode containing a Ir complex having a novel ligand as a phosphorescent emitter Cheng, Chien-Hong (TW) 2011-11-22 US disclosed
US-20080217606-A1 Organic light emitting diode containing a Ir complex having a novel ligand as a phosphorescent emitter Cheng, Chien-Hong (TW) 2008-09-11 US disclosed
US-20080217606-A1 Organic light emitting diode containing a Ir complex having a novel ligand as a phosphorescent emitter Cheng, Chien-Hong (TW) 2008-09-11 US disclosed
US-20080217606-A1 Organic light emitting diode containing a Ir complex having a novel ligand as a phosphorescent emitter Cheng, Chien-Hong (TW) 2008-09-11 US disclosed
US-6927020-B2 Silver halide color photographic material KONICA MINOLTA HOLDINGS, INC. (JP) 2005-08-09 US disclosed
US-20040157173-A1 Silver halide color photographic material KONICA MINOLTA HOLDINGS, INC. 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194578-A1 PLATINUM COMPLEX AND OLED USING THE SAME OCIAD2, POF1B, OCIAD1 SMN1; SMN2 3122/4885FDPS 2148/4885ALDH1A1 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.